Global Companion Animal Health Market
Dublin, Aug. 31, 2022 (GLOBE NEWSWIRE) — The “Global Companion Animal Health Market (2022-2027) by Indication, Animal, Distribution Channel, Geography, Competitive Analysis and the Impact of Covid-19 with Ansoff Analysis” report has been added to ResearchAndMarkets.com’s offering.
The Global Companion Animal Health Market is estimated to be USD 28.69 Bn in 2022 and is expected to reach USD 47.46 Bn by 2027, growing at a CAGR of 10.59%.
Market Dynamics
Market dynamics are forces that impact the prices and behaviors of the Global Companion Animal Health Market stakeholders. These forces create pricing signals which result from the changes in the supply and demand curves for a given product or service. Forces of Market Dynamics may be related to macro-economic and micro-economic factors. There are dynamic market forces other than price, demand, and supply. Human emotions can also drive decisions, influence the market, and create price signals. As the market dynamics impact the supply and demand curves, decision-makers aim to determine the best way to use various financial tools to stem various strategies for speeding the growth and reducing the risks.
Company Profiles
The report provides a detailed analysis of the competitors in the market. It covers the financial performance analysis for the publicly listed companies in the market. The report also offers detailed information on the companies’ recent development and competitive scenario. Some of the companies covered in this report are Zoetis, Merck., Boehringer Ingelheim, Elanco Animal Health, Ceva Sante Animale, Virbac, Vetoquinol, Dechra Pharmaceuticals, Chanelle Pharma, Kyoritsu Seiyaku, Zydus Animal Health and etc.
Countries Studied
America (Argentina, Brazil, Canada, Chile, Colombia, Mexico, Peru, United States, Rest of Americas)
Europe (Austria, Belgium, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Poland, Russia, Spain, Sweden, Switzerland, United Kingdom, Rest of Europe)
Middle-East and Africa (Egypt, Israel, Qatar, Saudi Arabia, South Africa, United Arab Emirates, Rest of MEA)
Asia-Pacific (Australia, Bangladesh, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Sri Lanka, Thailand, Taiwan, Rest of Asia-Pacific)
Competitive Quadrant
The report includes Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.
Ansoff Analysis
The report presents a detailed Ansoff matrix analysis for the Global Companion Animal Health Market. Ansoff Matrix, also known as Product/Market Expansion Grid, is a strategic tool used to design strategies for the growth of the company. The matrix can be used to evaluate approaches in four strategies viz. Market Development, Market Penetration, Product Development and Diversification. The matrix is also used for risk analysis to understand the risk involved with each approach. The analyst analyses the using the Ansoff Matrix to provide the best approaches a company can take to improve its market position. Based on the SWOT analysis conducted on the industry and industry players, the analyst has devised suitable strategies for market growth.
Why buy this report?
The report offers a comprehensive evaluation of the Global Companion Animal Health Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.
The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.
The report includes an in-depth market analysis using Porter’s 5 forces model and the Ansoff Matrix. In addition, the impact of Covid-19 on the market is also featured in the report.
The report also includes the regulatory scenario in the industry, which will help you make a well-informed decision. The report discusses major regulatory bodies and major rules and regulations imposed on this sector across various geographies.
The report also contains the competitive analysis using Positioning Quadrants, the analyst’s Proprietary competitive positioning tool.
Key Topics Covered:
1 Report Description
2 Research Methodology
3 Executive Summary
4 Market Dynamics
4.1 Drivers
4.1.1 Growing Prevalence of Zoonotic Diseases
4.1.2 Rising Demand for Pet Insurance With Growing Animal Health Expenditure
4.1.3 Initiatives by Various Government Agencies and Animal Associations
4.1.4 Growth in Companion Animal Ownership Rates
4.2 Restraints
4.2.1 Rising Pet Care Costs
4.2.2 Limited Number of New Product Developments
4.2.3 High Storage Cost of Vaccines
4.3 Opportunities
4.3.1 Lucrative Growth Opportunities in Emerging Markets
4.3.2 Growing Prevalence of Animal Diseases
4.3.3 Technological Advancements in Manufacturing Vaccines
4.4 Challenges
4.4.1 The Stringent Regulatory Approval Process for Drugs
4.4.2 Inadequate Surveillance and Reporting Systems of Vaccines
4.4.3 Diversity of Parasite Species
5 Market Analysis
5.1 Regulatory Scenario
5.2 Porter’s Five Forces Analysis
5.3 Impact of COVID-19
5.4 Ansoff Matrix Analysis
6 Global Companion Animal Health Market, By Indication
6.1 Introduction
6.2 Infectious Diseases
6.2.1 Parasiticides
6.2.2 Vaccines
6.2.3 Antibiotics and Antimicrobials
6.3 Dermatologic Diseases
6.3.1 Pain
6.3.2 Orthopaedic Diseases
6.3.3 Behavioral Disorders
7 Global Companion Animal Health Market, By Animal
7.1 Introduction
7.2 Dogs
7.3 Cats
7.4 Horses
8 Global Companion Animal Health Market, By Distribution Channel
8.1 Introduction
8.2 Veterinary Hospitals
8.3 Veterinary Clinics
8.4 Retail Pharmacies
8.5
9 Americas’ Companion Animal Health Market
9.1 Introduction
9.2 Argentina
9.3 Brazil
9.4 Canada
9.5 Chile
9.6 Colombia
9.7 Mexico
9.8 Peru
9.9 United States
9.10 Rest of Americas
10 Europe’s Companion Animal Health Market
10.1 Introduction
10.2 Austria
10.3 Belgium
10.4 Denmark
10.5 Finland
10.6 France
10.7 Germany
10.8 Italy
10.9 Netherlands
10.10 Norway
10.11 Poland
10.12 Russia
10.13 Spain
10.14 Sweden
10.15 Switzerland
10.16 United Kingdom
10.17 Rest of Europe
11 Middle East and Africa’s Companion Animal Health Market
11.1 Introduction
11.2 Egypt
11.3 Israel
11.4 Qatar
11.5 Saudi Arabia
11.6 South Africa
11.7 United Arab Emirates
11.8 Rest of MEA
12 APAC’s Companion Animal Health Market
12.1 Introduction
12.2 Australia
12.3 Bangladesh
12.4 China
12.5 India
12.6 Indonesia
12.7 Japan
12.8 Malaysia
12.9 Philippines
12.10 Singapore
12.11 South Korea
12.12 Sri Lanka
12.13 Thailand
12.14 Taiwan
12.15 Rest of Asia-Pacific
13 Competitive Landscape
13.1 Competitive Quadrant
13.2 Market Share Analysis
13.3 Strategic Initiatives
13.3.1 M&A and Investments
13.3.2 Partnerships and Collaborations
13.3.3 Product Developments and Improvements
14 Company Profiles
14.1 Ashish Life Science
14.2 Boehringer Ingelheim
14.3 Ceva Sante Animale
14.4 Chanelle Pharma
14.5 Dechra Pharmaceuticals
14.6 Eco Animal Health Group
14.7 Elanco Animal Health
14.8 Endovac Animal Health
14.9 Hipra
14.10 Indian Immunological
14.11 Inovet
14.12 Kyoritsu Seiyaku
14.13 Lutim Pharma
14.14 Merck.
14.15 Norbrook Holdings
14.16 Tianjin Ringpu Bio-Technology
14.17 Vetoquinol
14.18 Virbac
14.19 Zoetis
14.20 Zydus Animal Health and Investments
15 Appendix
For more information about this report visit https://www.researchandmarkets.com/r/wmnntx
Attachment
Global Companion Animal Health Market
A “superbubble” appears dangerously near its "final act" after the recent rally in U.S. stocks lured some investors back into the market just ahead of potential “tragedy,” according to Jeremy Grantham, the legendary co-founder of Boston-based investment firm GMO.
Nvidia Corp. shares fell in late trading Wednesday after the graphics-chip specialist disclosed that the U.S. government is seeking to restrict its data-center business in China.
The U.S.’s largest chip maker by market value says the new rule puts up to $400 million of quarterly sales into jeopardy.
A summer U.S. stock-market rally off lows for the year seen in June shuddered to a halt in August, leaving major indexes on track for monthly losses as investors braced for the start of a traditionally unpleasant month for equity bulls.
“If history repeats, the play will once again be a Tragedy. We must hope this time for a minor one,” famed investor Jeremy Grantham warned this week.
It should be obvious that billionaires don’t accumulate wealth by accident. Their success is predicated on observation and savvy investment, and a privileged background helps. Billionaires like Microsoft Corp. co-founder Bill Gates likely saw an opportunity for land investment to return tenfold, by way of food shortages, well ahead of time. So it should be no surprise that the real estate investing platform Arrived Homes, backed by Amazon.com Inc. founder Jeff Bezos is taking off. He had the for
Many Americans are surprised to see they have not prepared as well as they had hoped for retirement when they finally get ready to call it quits. The bad news is, you’ll probably have to make some realistic assumptions of what your retirement will look like. If you’ve lived primarily paycheck to paycheck in your working years, that may continue to feel the case in your retirement.
The Dow Jones fell amid weak new jobs data. A Warren Buffett stock took a tumble. BBBY stock cratered, with AMC stock also dipping.
Nio (NYSE: NIO) shares have been turbulent over the last month, and that continued Wednesday morning. Earlier this week, Deutsche Bank analyst Vincent Ha said his firm thinks Nio's third-quarter deliveries will be a little over 30,000 units. Investors may react again tomorrow, when Nio will report its August delivery numbers.
And if you’re behind? It’s OK boomer. There’s still some time to catch up.
In the latest trading session, Verizon Communications (VZ) closed at $41.81, marking a -1.69% move from the previous day.
Top trending stocks in after-hours trading.
Investor concerns have yet to abate, with worries given some added impetus last week when Fed Chair Jerome Powell said bluntly that the central bank is not done raising interest rates – and that the next couple of years are going to hurt. In one way, this is good news, as it signals clearly that the central bank will concentrate on combatting the high inflation that is weighing down the economy, but it also dramatically increases the risk that the Fed’s moves will spark a recession. The immediat
Okta Inc. shares plummeted in late trading Wednesday after executives revealed the software company faced issues stemming from integration of the $6.5 billion acquisition of Auth0.
The Australian has already splashed out over $1m on a four-bedroom mansion.
With a total net worth of $137 billion, Indian-born Gautam Adani’s extraordinary wealth gain in 2022 has far surpassed that of any other billionaire, many of whom have seen their fortunes drop this year, according to Bloomberg’s running tally. The world’s richest, Tesla (TSLA) Chief Executive Officer Elon Musk, has seen a loss of $18.9 billion this year to bring his fortune to $251 billion, while Amazon.com’s (AMZN) executive chairman Jeff Bezos and No. 2 on the wealthy list, has seen his fortune tumble $39 billion this year, to $153 billion. Bloomberg reported that Adani, a college dropout, vaulted into the top three on Monday, the first time a person from Asia has made it that high into the rankings.
Wall Street price targets for Tesla stock are rising after the electric-vehicle maker's Aug. 25 stock split. Here's why.
The conglomerate’s plan for resolving the largest single litigation in U.S. history in bankruptcy court went awry where other corporate defendants have succeeded.
(Bloomberg) — Few outside of India had heard of Gautam Adani just a few years ago. Now the Indian businessman, a college dropout who first tried his luck as a diamond trader before turning to coal, has become the world’s third-richest person. Most Read from BloombergAdani Becomes World’s Third Richest Trailing Only Musk, BezosElon Musk Attacks Twitter Deal Over Whistle-Blower as Feud EscalatesThere’s a New Recession Canary in the Coal Mine, Morgan Stanley SaysDOJ Response Raises Doubts on Trump
Making money in the S&P 500 got tougher again in August. But not impossible. All told, had you invested $10,000 in January and reinvested your money into the top stock currently in the S&P 500 each month this year, including Constellation Energy in August, you'd have $95,509 now, says an Investor's Business Daily analysis of data from S&P Global Market Intelligence and MarketSmith.
source
The post The Worldwide Companion Animal Health Industry is Expected to Reach $47 Billion by 2027 – Yahoo Finance appeared first on Vogue Wellness.
